Corcept Therapeutics (CORT) Asset Utilization Ratio (2013 - 2026)

Corcept Therapeutics has reported Asset Utilization Ratio for 14 years, with the latest figure at 0.98 in Q2 2026.

• Quarterly Asset Utilization Ratio rose 12.25% year-over-year to 0.98 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.98 (up 12.25% YoY) and the FY2025 annual result came in at 0.91, down 1.67% from the prior year.
• Asset Utilization Ratio grew to 0.98 in Q2 2026 per CORT's latest filing, from 0.93 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.98 in Q2 2026 and troughed at 0.69 in Q1 2023.
• A 5-year average of 0.83 and a median of 0.83 in 2024 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio jumped 40.93% in 2022, then dropped 19.2% in 2023.
• Over 5 years, Asset Utilization Ratio stood at 0.72 in 2022, then rose by 10.27% to 0.79 in 2023, then gained by 4.69% to 0.83 in 2024, then climbed by 10.39% to 0.92 in 2025, then rose by 6.34% to 0.98 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.98, 0.93, and 0.92 for Q2 2026, Q1 2026, and Q4 2025 respectively.